Stocks › VAXX
VAXX
VAXX·USD
$0.06
+0.05 (+54900.00%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
VAXX
VAXX
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
VAXXS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of VAXX by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Rick ScottSenate · R · FL |
VAXXVAXX · Stock |
Sale $1,001 - $15,000 |
Jan 19, 2024 | Dec 20, 2023 | Filing ↗ |
| Rick ScottSenate · R · FL |
VAXXVAXX · Stock |
Sale $1,001 - $15,000 |
Jan 19, 2024 | Dec 20, 2023 | Filing ↗ |
| Rick ScottSenate · R · FL |
VAXXVAXX · Stock |
Sale $1,001 - $15,000 |
Jan 19, 2024 | Dec 20, 2023 | Filing ↗ |
Whale Activity
Position changes in VAXX reported for 2024-03-31 by 4 tracked institutional filers
- Increased2
- New1
- Held0
- Decreased1
- Closed0
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 2.6M | $1.9M | decreased |
| Vanguard Group | 2.4M | $1.7M | increased |
| Millennium Management LLC | 48.2K | $35K | increased |
| Renaissance Technologies | 35.1K | $25 | new |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by VAXX insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
103 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Prime Movers Lab Fund I LP10% owner | Sale | −10.3K | $1.67 | $17K | Sep 8, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −4,217 | $1.67 | $7K | Sep 8, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −2,395 | $1.67 | $4K | Sep 8, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −25.1K | $1.67 | $42K | Sep 8, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −5,911 | $1.67 | $10K | Sep 8, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −8,378 | $1.79 | $15K | Sep 7, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −3,413 | $1.79 | $6K | Sep 7, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −1,939 | $1.79 | $3K | Sep 7, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −20.3K | $1.79 | $36K | Sep 7, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −4,786 | $1.79 | $9K | Sep 7, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −2,189 | $1.88 | $4K | Sep 6, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −892 | $1.88 | $2K | Sep 6, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −507 | $1.88 | $953 | Sep 6, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −5,308 | $1.88 | $10K | Sep 6, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −1,251 | $1.88 | $2K | Sep 6, 2023 | Form 4 ↗ |
| Diamandis PeterDirector | Option exercise | +46.5K | $1.21 | $56K | Apr 26, 2023 | Form 4 ↗ |
| Diamandis PeterDirector | Option exercise | +429.0K | $0.57 | $245K | Apr 26, 2023 | Form 4 ↗ |
| Sloss Dakin10% owner | Sale | −405.2K | $3.35 | $1.4M | Jan 23, 2023 | Form 4 ↗ |
| Sloss Dakin10% owner | Sale | −95.5K | $3.35 | $320K | Jan 23, 2023 | Form 4 ↗ |
| Prime Movers Lab Fund I LP10% owner | Sale | −11.1K | $2.57 | $29K | Dec 2, 2022 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding VAXX · SEC Form N-PORT
Funds report their holdings by CUSIP, and VAXX could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming VAXX as client
No lobbying filings found naming VAXX as the client.
Government Contracts
Federal awards to VAXX · USAspending
No federal contract awards found for VAXX.
U.S. Patents
Recent USPTO applications naming VAXX
No USPTO patent applications found for VAXX.
Annual Financials
From VAXX's 10-K filings · XBRL
No annual XBRL figures on record for VAXX. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No stock splits in VAXX's price history.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About VAXX
From SEC EDGAR company records
No company profile on record.